Cibc World Markets Corp Biocryst Pharmaceuticals Inc Transaction History
Cibc World Markets Corp
- $14.8 Billion
- Q2 2025
A detailed history of Cibc World Markets Corp transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Cibc World Markets Corp holds 25,810 shares of BCRX stock, worth $177,056. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,810
Previous 45,850
43.71%
Holding current value
$177,056
Previous $343,000
32.65%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding BCRX
# of Institutions
315Shares Held
201MCall Options Held
930KPut Options Held
553K-
Vanguard Group Inc Valley Forge, PA20.5MShares$141 Million0.0% of portfolio
-
Black Rock Inc. New York, NY20MShares$137 Million0.0% of portfolio
-
State Street Corp Boston, MA8.51MShares$58.3 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ8.46MShares$58.1 Million9.06% of portfolio
-
Alkeon Capital Management LLC New York, NY5.71MShares$39.2 Million0.09% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.28B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...